BRIXELLE
Live / Registered — Registered (as of 23 Aug 2022)
What this means for you
Registered since 23 Aug 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79302745
- Registration number
- 6822946
- Mark type
- Stylized text
- Filed
- 01 Dec 2020
- Published for opposition
- 07 Jun 2022
- Registered
- 23 Aug 2022
- Attorney of record
- James R Menker
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical agents affecting sensory organs; pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of musculo-skeletal disorders; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for peripheral nervous system; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical products for the treatment of viral diseases; pharmaceuticals for the treatment of erectile dysfunction; vaccines; anti-inflammatory preparations; medicines for intestinal disorders; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; ophthalmic preparations; biological preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical agents for epidermis; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; enzymes for medical purposes; diagnostic preparations for medical or veterinary purposes; immunoassay reagents for medical use; medical reagents for testing genetic identity for medical purposes; pharmaceutical preparations for neurological disease; pharmaceutical preparations for inflammatory diseases; pharmaceutical preparations for ocular and intraocular surgery; pharmaceutical preparations for rare autoimmune diseases in the nature of autoimmune lymphoproliferative syndrome, lupus, and multiple sclerosis; pharmaceutical products for the treatment of rare autoimmune diseases and disorders; pharmaceutical products for the prevention and treatment of rare genetic diseases affecting red blood cells; medicated ointments for treating dermatological conditions; antibiotic ointments; mentholated ointment for medical use; anti-inflammatory ointments; chemical reagents for purposes of medical diagnosis; diagnostic preparations for diagnosing inflammatory diseases; diagnostic radiopharmaceutical preparations; pharmaceutical and biological preparations for use in diagnosis, namely, for use as ultrasound and X-ray contrast reagents; human vaccine preparations; pharmaceutical preparations acting on the central nervous system; preparations for the treatment of asthma; medicines for dental purposes; dermatological pharmaceutical products; pharmaceutical preparations for skin care; pharmaceutical preparations for treating skin disorders; antibiotics; anti-cancer preparations; tumor suppressing agents; pharmaceutical products for treating respiratory diseases
Owner
- Bilix Co., Ltd., KR
- Bilix Co., Ltd., KR
- Bilix Co., Ltd., KR
Prosecution history
- 27 Dec 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 01 Dec 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 01 Dec 2022 — FINAL DISPOSITION PROCESSED
- 23 Nov 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 23 Aug 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Aug 2022 — REGISTERED-PRINCIPAL REGISTER
- 12 Jul 2022 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 22 Jun 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 22 Jun 2022 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 07 Jun 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jun 2022 — PUBLISHED FOR OPPOSITION
- 18 May 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 May 2022 — ASSIGNED TO LIE
- 29 Apr 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Apr 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED